World-first Parkinson’s stem cells trial

News

Author: Simge Eva DoganPublished: 9 August 2018

Prep: Cook: Serves:

Scientists at a Japanese university will carry out a world-first clinical trial transplanting reprogrammed stem cells into the brains of seven people with Parkinson’s.

Researchers believe the process – which was tested on monkeys last year – will allow the brain to create dopamine to counter the effects of Parkinson’s.

Shinya Yamanaka, who is working on the study and won the Nobel Prize in 2012 for his work with stem cells, said: “We intend to carry on conducting our research carefully, yet expeditiously, in coordination with Kyoto University Hospital, so that new treatment will be brought to patients as soon as possible.”

Researchers are hoping to create a treatment that will be covered by national health insurance in Japan.

To read more on this topic click here.

For more information on the latest Parkinson’s research please visit the EPDA website.

Last Month

Next Month

Go Back

Share this story

Comments

Advances

Tremor-reducing GyroGlove set to launch in 2017

Volunteer testers wanted as launch date nears

How this graphic novelist drew through his “intolerable Parkinson’s pain”

Cartoonist opens up about his new book - 10 years into diagnosis

Setting a Guinness World Record for Parkinson’s was the proudest moment of my life

105km swim for Parkinson’s verified as new Guinness World Record

Could a transplant lower the risk of Parkinson’s?

Researchers at Washington University School of Medicine, US, have found that having a heart, kidney, lung or bone marrow transplant could reduce the risk of developing Parkinson’s. As part of the study, published in medical journal ‘Parkinsonism & Related Disorders’, the team assessed data of just under 200,000 patients – 89,790 of whom had Parkinson’s. The results revealed that individuals who had a transplant were 37% less likely to develop Parkinson’s. This could be due to the immunosuppressant medication patients receive before undergoing a transplant, which researchers believe may help slow neurodegeneration as it reduces inflammation in the brain. The study said: “This study provides evidence that tissue transplant may be associated with a lower PD [Parkinson’s disease] risk, warranting further investigation to identify factors that mediate this relationship.”

Groundbreaking Parkinson’s trial publishes results

A breakthrough Parkinson’s trial that featured in a two-part documentary on UK television channel BBC Two has published its results. The study, which featured in the documentary ‘The Parkinson’s Drug Trial: A miracle cure?’, aimed to investigate whether it was possible to restore damaged neurons by administering protein Glial Cell Line Derived Neurotrophic Factor (GDNF). As part of the trial, scientists initially infused GDNF into the brains of six participants living with the condition. Researchers then invited a further 35 individuals with Parkinson’s to take part, with approximately half being administered with a placebo infusion. Although not conclusive, the results suggest that GDNF had an impact on the brain and researchers believe the topic is worthy of further study. Dr Alan Whone, principal investigator on the trial, said: “This represents some of the most compelling evidence yet that we may have a means to possibly reawaken and restore the dopamine brain cells…

Course for Parkinson’s nurses launches in Slovenia

The International Parkinson and Movement Disorder Society is hosting its third summer school for nurses specialising in Parkinson’s. The course – which will be held from 10-12 May in Ljubljana, Slovenia – will focus on the management of the motor and non-motor symptoms of the condition. Students will also attend lectures, examine Parkinson’s patients and discuss treatment plans with experts. All lectures will be presented in English. Heather Vitale, senior programme manager at the International Parkinson and Movement Disorder Society, said: “This course offers a unique opportunity for nurses to enhance their knowledge in Parkinson’s disease, while also learning and networking with their peers through case study presentations and small group discussions.” Registration closes 26 April 2019 and costs USD $350.

All fields required

First name*
Last name*
Email address*
Enter Email Confirm Email
Country of residence*
About me*
- I have Parkinson's disease
- I am a partner / carer / family / friend of someone who has Parkinson's
- I am a healthcare professional with an interest in Parkinson's
- I work for a Parkinson's disease organisation
- Other
CAPTCHA
*
- By proceeding you agree to our
Name
This field is for validation purposes and should be left unchanged.

World-first Parkinson’s stem cells trial

News

Author: Simge Eva DoganPublished: 9 August 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Advances

Tremor-reducing GyroGlove set to launch in 2017

Perspectives

How this graphic novelist drew through his “intolerable Parkinson’s pain”

Interviews

Setting a Guinness World Record for Parkinson’s was the proudest moment of my life

Could a transplant lower the risk of Parkinson’s?

Groundbreaking Parkinson’s trial publishes results

Course for Parkinson’s nurses launches in Slovenia

{title}

Subscribe

World-first Parkinson’s stem cells trial

News

Author: Simge Eva DoganPublished: 9 August 2018

Prep: Cook: Serves:

Last Month

Next Month

Share this story

Comments

Related articles

Advances

Tremor-reducing GyroGlove set to launch in 2017

Perspectives

How this graphic novelist drew through his “intolerable Parkinson’s pain”

Interviews

Setting a Guinness World Record for Parkinson’s was the proudest moment of my life

Could a transplant lower the risk of Parkinson’s?

Groundbreaking Parkinson’s trial publishes results

Course for Parkinson’s nurses launches in Slovenia

{title}

Subscribe

Sign in